Synapse - Works

Results (127)

Reduced-intensity compared to nonmyeloablative conditioning in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic stem cell transplantation

Journal Article

Nath, K.; Peterson, K.; Brown, S.; Devlin, S.; Rodriguez, N.; Barker, J.; Giralt, S.; Gyurkocza, B.; Jakubowski, A.; Papadopoulos, E.; more...
Transplantation and Cellular Therapy (2024)

Fulltext@MSK | Save

Topical ruxolitinib for chronic cutaneous GvHD: Promising results of a phase 2 clinical trial

Meeting Abstract

Markova, A.; Papadopoulos, E. B.; Dusza, S.; Ostojić, J.; Ai, R.; Maier, T.; Lacouture, M.; Tamari, R.; Gyurkocza, B.; Shaffer, B. C.; more...
Blood (2023)

Fulltext@MSK | Save

A phase II trial of prophylactic anakinra to prevent neurotoxicity in patients receiving anti-CD19 CAR T-cell therapy for relapsed or refractory lymphoma: Final results from cohort 2

Meeting Abstract

Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G. L.; Dahi, P. B.; Lin, R. J.; Scordo, M.; Perales, M. A.; Leslie, L. A.; more...
Blood (2023)

Fulltext@MSK | Save

Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T-cell therapy outcome

Meeting Abstract

Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J. R.; Devlin, S. M.; Shah, G. L.; Fregonese, B.; Bedmutha, A.; Wills, B.; Tomas, A. A.; more...
Blood (2023)

Fulltext@MSK | Save

18F-FDG PET/CT imaging biomarkers for car-T cell therapy outcomes in large-B-cell lymphoma

Meeting Abstract

Leithner, D.; Flynn, J. R.; Devlin, S. M.; Mauguen, A.; Fei, T.; Zeng, S.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M.; Luttwak, E.; more...
Blood (2023)

Fulltext@MSK | Save

Evaluation of urine BKV by day 40 posthematopoietic cell transplant as predictor of BKV-associated hemorrhagic cystitis

Meeting Abstract

Lee, Y. J.; Scordo, M.; Glezerman, I.; Han, G.; Perales, M. A.; Giralt, S.; Jakubowski, A.; Papanicolaou, G.
Bone Marrow Transplantation (2023)

Fulltext@MSK | Save

A reproducible inflammatory biomarker signature identifies non-Hodgkin lymphoma patients at high risk of CAR-T treatment failure across different cohorts

Meeting Abstract

Raj, S.; Perales, M. A.; Fei, T.; Fein, J.; Tomas, A. A.; De LaPuerta, M. C.; Dahi, P.; Danylesko, I.; Epstein-Peterson, Z.; Fried, S.; more...
Bone Marrow Transplantation (2023)

Fulltext@MSK | Save

The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantation

Journal Article

Elias, S.; Brown, S.; Devlin, S. M.; Barker, J. N.; Cho, C.; Chung, D. J.; Dahi, P. B.; Giralt, S.; Gyurkocza, B.; Jakubowski, A. A.; more...
British Journal of Haematology (2023)

Fulltext@MSK | Save

Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphoma

Journal Article

Scordo, M.; Flynn, J. R.; Gonen, M.; Devlin, S. M.; Parascondola, A.; Tomas, A. A.; Shouval, R.; Brower, J.; Porter, D. L.; Schuster, S. J.; more...
Blood Advances (2023)

Fulltext@MSK | Save

Association between busulfan exposure and survival in patients undergoing a CD34(+) selected stem cell transplantation

Journal Article

Tamari, R.; Scordo, M.; Kunvarjee, B. M.; Proli, A.; Lin, A.; Flynn, J.; Cho, C.; Devlin, S.; Klein, E.; Boulad, F.; more...
Blood Advances (2023)

Fulltext@MSK | Save